组别

常规治疗组

特殊治疗组

T/χ²/z值

P值

SDNN (ms)

114.27 ± 32.94

129.39 ± 29.41^a

−3.67

0.000

SDANN (ms)

105.81 ± 30.81

1118.88 ± 29.51

−3.304

0.001

SDNN index (ms)

45.13 ± 12.77

51.45 ± 13.92^a

−3.323

0.000

RMSSD (ms)

31.73 ± 9.93^b

34.55 ± 9.75^a

−2.194

0.029

PNN50 (%)

7 (2, 10)

9 (4, 14)

−2.696

0.007

HF (ms)

128 (78.8, 103.4)

163.4 (121.7, 246.6)

−3.422

0.001

LF (ms)

177.9 (112.5, 295.3)

212 (128.5, 296.5)

−1.575

0.115

LF/HF

1.3 (0.97, 1.74)

1.13 (0.89, 1.51)^a

−2.397

0.017

并发症

复发性脑梗死(例)

3 (2.2%)

2 (1.9%)

0

1

心肌梗死(例)

2 (1.5%)

1 (1%)

0

1

心律失常(例)

14 (10.3%)

4 (3.9%)

3.459

0.063

心率衰竭(例)

3 (2.2%)

1 (1%)

0.052

0.82

死亡(例)

1 (0.7%)

0 (0)

1

心脑血管并发症总数(例)

22 (16.2%)

7 (6.8%)

4.837

0.028